98%
921
2 minutes
20
Infants and children in low- and middle-income countries (LMICs) are frequently exposed to a range of environmental risk factors which may negatively affect their neurocognitive development. The mechanisms by which factors such as undernutrition and poverty impact development and cognitive outcomes in early childhood are poorly understood. This lack of knowledge is due in part to a paucity of objective assessment tools which can be implemented across different cultural settings and in very young infants. Over the last decade, technological advances, particularly in neuroimaging, have opened new avenues for research into the developing human brain, allowing us to investigate novel biological associations. This paper presents functional near-infrared spectroscopy (fNIRS), electroencephalography (EEG) and eye tracking (ET) as objective, cross-cultural methods for studying infant neurocognitive development in LMICs, and specifically their implementation in rural Gambia, West Africa. These measures are currently included, as part of a broader battery of assessments, in the Brain Imaging for Global Health (BRIGHT) project, which is developing brain function for age curves in Gambian and UK infants from birth to 24 months of age. The BRIGHT project combines fNIRS, EEG and ET with behavioural, growth, health and sociodemographic measures. The implementation of these measures in rural Gambia are discussed, including methodological and technical challenges that needed to be addressed to ensure successful data acquisition. The aim is to provide guidance to other groups seeking to implement similar methods in their research in other LMICs to better understand associations between environmental risk and early neurocognitive development.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719506 | PMC |
http://dx.doi.org/10.12688/gatesopenres.12951.2 | DOI Listing |
Mol Genet Metab Rep
December 2025
Pediatric Critical Care Medicine, Department of Pediatrics NewYork-Presbyterian Morgan Stanley Children's Hospital, Columbia University Medical Center, New York, NY, United States of America.
encodes NADH: ubiquinone oxidoreductase core subunit V1, a key component of mitochondrial Complex 1. Biallelic pathogenic variants in this gene produce a broad and variable phenotypic spectrum in affected individuals, including ophthalmoplegia, developmental delays, brain imaging abnormalities, and recurrent episodes of emesis and lactic acidemia. We report female siblings compound heterozygous for two missense variants (Arg40Gln, Val245Met) in with unusual presentations of this condition.
View Article and Find Full Text PDFNIHR Open Res
June 2025
Neuropsychology Service, Psychological & Mental Health Services, Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, UK.
Background: Medical treatments have improved survival rates for paediatric brain tumour (PBT), but the condition and treatment continue to be associated with significant cognitive morbidity. Nearly all survivors will experience some degree of cognitive impairment (neurocognitive 'late effects') that has a cascading impact on the development of intellectual and academic skills, quality of life, mental health, vocational attainment, and functional independence. Longstanding cognitive fatigue is also a prevalent symptom for survivors of PBT and further impacts engagement with therapeutic interventions and quality of life.
View Article and Find Full Text PDFAnn Neurosci
September 2025
Department of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Background: Children with chronic kidney disease (CKD) are at risk of inferior neurocognitive outcomes. As the brain develops rapidly during the early years of life, we wanted to find out the impact of CKD on neurocognition when it occurs during this time and any disease-associated risk factors.
Methods: A cross-sectional case-control study was conducted in the Paediatric Nephrology Clinic, PGIMER, Chandigarh.
J Diabetes Res
September 2025
Department of Immunochemistry, Institution of Chemical Engineering, Ural Federal University, Yekaterinburg, Russia.
Health-related quality of life (HRQoL) has become a critical focus in managing Type 2 diabetes mellitus (T2DM), emphasizing the need to integrate physiological, psychological, and social dimensions into clinical practice. Despite the growing prevalence of T2DM worldwide, particularly in low- and middle-income countries, the global research landscape of HRQoL remains unevenly distributed. This study is aimed at systematically analyzing the global research trends, key contributors, and influencing factors of HRQoL in patients with T2DM using bibliometric methods, providing insights to guide future research and targeted interventions.
View Article and Find Full Text PDFFront Nutr
August 2025
Department of Neurology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Objective: While soy products can potentially affect cognitive function through various mechanisms, the dose-response connection of high soy consumption with major neurocognitive disorder or cognitive impairment remains unclear.
Methods: A comprehensive retrieval was performed on PubMed, Embase, Cochrane Library, and Web of Science databases up to September 2024, to identify prospective or cohort studies (without language restrictions) examining the link between high soy consumption and the likelihood of developing major neurocognitive disorder or cognitive impairment. Stata (V15) was employed for data analysis, and a restricted cubic spline (RCS) model was employed for examining the dose-response effect.